Allison R. Fleming, NP
Nurse Practitioners (Acute Care Nurse Practitioner)
- Medicare participating
At a glance
- In the NPI registry since
- 2019
- Medicare patients seen, 2024
- 11
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2019Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Acute Care Nurse Practitioner primary
CA license 95021129 · GA license RN272584
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 11
- Services billed
- 21
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 47 | 28 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 31 | 22 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 21 | 12 |
| Established patient office or other outpatient visit, 30-39 minutes | 18 | 18 |
| Established patient office or other outpatient visit, 20-29 minutes | 13 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 3 payments worth $56.14 in total to this clinician.
| Revance Therapeutics, Inc. | $22.82 |
|---|---|
| Genentech USA, Inc. | $16.93 |
| Janssen Biotech, Inc. | $16.39 |
| Food and Beverage | $56.14 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.